Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06991114 · Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), and more
NCT06583395 · Amyotrophic Lateral Sclerosis (ALS), Angina, Stable, and more
NCT06684847 · Primary Sjogrens Disease
NCT07229144 · Sjogrens Disease, Idiopathic Inflammatory Myopathy (IIM)
St. Jude Hospital Yorba Linda
Fullerton, California
Riverside Medical Clinic
Riverside, California
Colorado Arthritis Associates
Lakewood, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions